Intra-tumoral molecular heterogeneity in benign and malignant pheochromocytomas and extra-adrenal sympathetic paragangliomas

Endocrine-Related Cancer

Volumn 17, Issue 3, 2010, Pages 653-662

  Korpershoek, Esther ^a   Stobbe, Claudia K ^a   Van Nederveen, Francien H ^a   De Krijger, Ronald R ^a   Dinjens, Winand N M ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER GENETICS; CHROMOSOME 1P; CHROMOSOME 3Q; CLINICAL ARTICLE; DNA EXTRACTION; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; PARAGANGLIOMA; PHEOCHROMOCYTOMA; ADRENAL TUMOR; CYTOCHEMISTRY; GENETIC VARIABILITY; GENETICS; HUMAN CHROMOSOME; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

DNA;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; CHROMOSOMES, HUMAN; DNA, NEOPLASM; FEMALE; GENETIC VARIATION; HISTOCYTOCHEMISTRY; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; PARAGANGLIOMA; PHEOCHROMOCYTOMA; YOUNG ADULT;

EID: 77956362996     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-10-0072     Document Type: Article

References (24)

1. Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Roqueplo AP et al. 2007 Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. Journal of Clinical Endocrinology and Metabolism 92 3822-3828. (Pubitemid 47607629)
2. Bachtiary B, Boutros PC, Pintilie M, Shi W, Bastianutto C, Li JH, Schwock J, Zhang W, Penn LZ, Jurisica I et al. 2006 Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity. Clinical Cancer Research 12 5632-5640. (Pubitemid 44629589)
3. Bausch B, Borozdin W, Mautner VF, Hoffmann MM, Boehm D, Robledo M, Cascon A, Harenberg T, Schiavi F, Pawlu C et al. 2007 Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. Journal of Clinical Endocrinology and Metabolism 92 2784-2792.
4. Benn DE, Richardson AL, Marsh DJ & Robinson BG 2006 Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes. Annals of the New York Academy of Sciences 1073 104-111.
5. Blackhall FH, Pintilie M, Wigle DA, Jurisica I, Liu N, Radulovich N, Johnston MR, Keshavjee S & Tsao MS 2004 Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection. Neoplasia 6 761-767.
6. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W et al. 1996 Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Research 56 2488-2492. (Pubitemid 26170679)
7. Cascon A, Ruiz-Llorente S, Rodriguez-Perales S, Honrado E, Martinez-Ramirez A, Leton R, Montero-Conde C, Benitez J, Dopazo J, Cigudosa JC et al. 2005 A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma. Genes, Chromosomes and Cancer 42 260-268. (Pubitemid 40171190)
8. Cascon A, Pita G, Burnichon N, Landa I, Lopez-Jimenez E, Montero-Conde C, Leskela S, Leandro-Garcia LJ, Leton R, Rodriguez-Antona C et al. 2009 Genetics of pheochromocytoma and paraganglioma in Spanish patients. Journal of Clinical Endocrinology and Metabolism 94 1701-1705.
9. Dannenberg H, Speel EJ, Zhao J, Saremaslani P, van Der Harst E, Roth J, Heitz PU, Bonjer HJ, Dinjens WN, Mooi WJ et al. 2000 Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas. American Journal of Pathology 157 353-359. (Pubitemid 30626902)
10. Diaz-Cano SJ, de Miguel M, Blanes A, Tashjian R, Galera H & Wolfe HJ 2000 Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates. Journal of Pathology 192 221-228.
11. Edstrom E, Mahlamaki E, Nord B, Kjellman M, Karhu R, Hoog A, Goncharov N, Teh BT, Backdahl M & Larsson C 2000 Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology. American Journal of Pathology 156 651-659. (Pubitemid 30643820)
12. Gaal J, van Nederveen FH, Erlic Z, Korpershoek E, Oldenburg R, Boedeker CC, Kontny U, Neumann HP, Dinjens WN & de Krijger RR 2009 Parasympathetic paragangliomas are part of the Von Hippel-Lindau syndrome. Journal of Clinical Endocrinology and Metabolism 94 4367-4371.
13. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, Plouin PF & Jeunemaitre X 2003 Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Research 63 5615-5621. (Pubitemid 37139886)
14. Hensen EF, Jordanova ES, van Minderhout IJ, Hogendoorn PC, Taschner PE, van der Mey AG, Devilee P & Cornelisse CJ 2004 Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 23 4076-4083. (Pubitemid 38747938)
15. Jarbo C, Buckley PG, Piotrowski A, Mantripragada KK, Benetkiewicz M, de Stahl TD, Langford CF, Gregory SG, Dralle H, Gimm O et al. 2005 Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH. International Journal of Cancer 118 1159-1164.
16. Klein CA 2009 Parallel progression of primary tumours and metastases. Nature Reviews. Cancer 9 302-312.
17. Korpershoek E, Van Nederveen FH, Dannenberg H, Petri BJ, Komminoth P, Perren A, Lenders JW, Verhofstad AA, De Herder WW, De Krijger RR et al. 2006 Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience. Annals of the New York Academy of Sciences 1073 138-148. (Pubitemid 44912006)
18. Lenders JW, Eisenhofer G, Mannelli M & Pacak K 2005 Phaeochromocytoma. Lancet 366 665-675.
19. Lui WO, Chen J, Glasker S, Bender BU, Madura C, Khoo SK, Kort E, Larsson C, Neumann HP&Teh BT 2002 Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome. Oncogene 21 1117-1122. (Pubitemid 34174524)
20. van Nederveen F, Korpershoek E, Deleeuw R, Verhofstad AA, Lenders JW, Dinjens W, Lam W & de Krijger R 2009 Array-CGH in sporadic benign pheochromocytomas. Endocrine-Related Cancer 16 505-513.
21. Nenning H, Rassler J & Minh DH 1997 Heterogeneity of DNA distribution pattern in renal tumours. Analytical Cellular Pathology 14 9-17. (Pubitemid 27418103)
22. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K et al. 2002 Germ-line mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine 346 1459-1466.
23. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez- Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS et al. 2007 Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nature Clinical Practice. Endocrinology & Metabolism 3 92-102. (Pubitemid 46146962)
24. Sayagues JM, Tabernero MD, Maillo A, Espinosa A, Rasillo A, Diaz P, Ciudad J, Lopez A, Merino M, Goncalves JM et al. 2004 Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions? Journal of Molecular Diagnostics 6 316-325.